Doximity Q1 FY2023 revenue $90.6M (+25% YoY); appoints Phoebe Yang to board

Doximity, Inc.

2023-Q1 EPS reported $0.10 revenue$90,639,000

Revenue $90.6M (+25% YoY); GAAP net income $22.4M (25% margin) vs $26.3M (36%) YoY.
Adjusted EBITDA $33.5M (37% margin); non-GAAP diluted EPS $0.14 vs $0.11 YoY.
Operating cash flow $44.8M (+35%); free cash flow $42.6M (+32%).
Guidance: Q2 revenue $99.5-100.5M, adj. EBITDA $40-41M; FY2023 revenue $424-432M, adj. EBITDA $178-186M.
Appointed Phoebe L. Yang (GM, AWS Healthcare) to board, replacing Gilbert Kliman; initial RSU grant $350K.

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Phoebe L. Yang Watkin

Director

DOCS · Doximity, Inc.

Effective: 2022-08-02
Filed: August 4, 2022, 7:59 PM ET

On August 2, 2022, the Board appointed Phoebe L. Yang Watkin to serve as a Class III director of the Board, filling the vacancy created by the departure of Dr. Kliman from the Board, effective immediately, until the annual meeting of the Doximity’s stockholders to be held in calendar 2024

Departed

Gilbert Kliman

Director

DOCS · Doximity, Inc.

Effective: 2022-08-02
Successor: Phoebe L. Yang Watkin
Filed: August 4, 2022, 7:59 PM ET

On August 2, 2022, Gilbert Kliman, M.D. informed the board of directors (the "Board") of Doximity of his intention to step down from his role as a director on the Board, including his membership of the nominating and governance committee and the compensation committees of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Phoebe L. Yang Watkin was appointed as Director at Doximity, Inc..

Action: appointed
Role: Director

Exact text from the filing

On August 2, 2022, the Board appointed Phoebe L. Yang Watkin to serve as a Class III director of the Board, filling the vacancy created by the departure of Dr. Kliman from the Board, effective immediately, until the annual meeting of the Doximity’s stockholders to be held in calendar 2024

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Gilbert Kliman departed as Director at Doximity, Inc..

Action: stepped down
Role: Director

Exact text from the filing

On August 2, 2022, Gilbert Kliman, M.D. informed the board of directors (the "Board") of Doximity of his intention to step down from his role as a director on the Board, including his membership of the nominating and governance committee and the compensation committees of the Board, effective immediately.

View on SEC.gov

Doximity, Inc. filing history →

Source: SEC EDGAR

accession 0001516513-22-000070

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.